(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

Catalog No. :
ACMRNZ724
CAS No. :
1585969-16-9
Molecular Formula :
C21H15Br2NO
Molecular Weight :
457.17

IUPAC Name:(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole
IUPAC Name(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole
Molecular FormulaC21H15Br2NO
Molecular Weight457.17
SMILESBrC1=CC2=C(C=C1)N1[C@H](C2)C2=C(C=C(Br)C=C2)O[C@H]1C1=CC=CC=C1
InChI KeyHACUEQQWPJQVLD-CTNGQTDRSA-N
Synonym(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole;(6S,12aR)-3,10-Dibromo-12,12a-dihydro-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine;6H-Indolo[1,2-c][1,3]benzoxazine, 3,10-dibromo-12,12a-dihydro-6-phenyl-, (6S,12aR)-;(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydroindolo[1,2-c][1,3]benzoxazine
CAS No.1585969-16-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMRNZ724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMRNZ724 route product structure diagram
    ACMRNZ7241585969-16-9
Inquiry

2. ACMRNZ724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMRNZ724 route product structure diagram
    ACMRNZ7241585969-16-9
Inquiry

Comments (0)